CDK-independent activation of estrogen receptor by cyclin D1

Cell

Volumn 88, Issue 3, 1997, Pages 405-415

  Zwijsen, Renate M L ^b   Wientjens, Ellen ^b   Klompmaker, Rob ^b   Van der Sman, Jeroen ^b   Bernards, René ^a   Michalides, Rob J A M ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; ESTROGEN; ESTROGEN RECEPTOR;

ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

EID: 0030968438     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81879-6     Document Type: Article

References (50)

1. All, S., Metzger, D., Bornert, J.M., and Chambon, P. (1993). Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J. 12, 1153-1160.
2. Bartkova, J., Lukas, J., Muller, H., Lutzhoft, D., Strauss, M., and Bartek, J. (1994). Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57, 353-361.
3. Bartkova, J., Lukas, J., Muller, H., Strauss, M., Gusterson, B., and Bartek, J. (1995). Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res. 55, 949-956.
4. Beato, M. (1991). Transcriptional control by nuclear receptors. [review]. FASEB J. 5, 2044-2051.
5. Beato, M., Herrlich, P., and Schuetz, G. (1995). Steroid hormone receptors: many actors in search of a plot. Cell 83, 851-857.
6. Beijersbergen, R.L., Carlee, L., Kerkhoven, R.M., and Bernards, R. (1995). Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev. 9, 1340-1353.
7. Berry, M., Metzger, D., and Chambon, P. (1990). Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9, 2811-2818.
8. DeFriend, D.J., Howell, A., Nicholson, R.I., Anderson, E., Dowsett, M., Mansel, R.E., Blamey, R.W., Bundred, N.J., Robertson, J.F., Saunders, C., et al. (1994). Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. Cancer Res. 54, 408-414.
9. Dowdy, S.F., Hinds, P.W., Louie, K., Reed, S.I., Arnold, A., and Weinberg, R.A. (1993). Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73, 499-511.
10. Dubik, D., and Shiu, R.P. (1988). Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J. Biol. Chem. 263, 12705-12708.
11. Evans, R.M. (1988). The steroid and thyroid hormone receptor superfamily. [review]. Science 240, 889-895.
12. Ewen, M.E., Sluss, H.K., Sherr, C.J., Matsushime, H., Kato, J., and Livingston, D.M. (1993). Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73, 487-497.
13. Fantl, V., Stamp, G., Andrews, A., Rosewell, I., and Dickson, C. (1995). Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9, 2364-2372.
14. Graham, F.L., and van der Eb, A.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
15. Hinds, P.W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S.I., and Weinberg, R.A. (1992). Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70, 993-1006.
16. Hinds, P.W., Dowdy, S.F., Eaton, E.N., Arnold, A., and Weinberg, R.A. (1994). Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA 91, 709-713.
17. Ignar-Trowbridge, D.M., Teng, C.T., Ross, K.A., Parker, M.G., Korach, K.S., and McLachlan, J.A. (1993). Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol. Endocrinol. 7, 992-998.
18. Inaba, T., Matsushime, H., Valentine, M., Roussel, M.F., Sherr, C.J., and Look, A.T. (1992). Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 13, 565-574.
19. Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., Metzger, D., and Chambon, P. (1995). Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase. Science 270, 1491-1494.
20. Kim, S.J., Onwuta, U.S., Lee, Y.I., Li, R., Botchan, M.R., and Robbins, P.D. (1992). The retinoblastoma gene product regulates Sp1-mediated transcription. Mol. Cell. Biol. 12, 2455-2463.
21. Klein-Hitpass, L., Schorpp, M., Wagner, U., and Ryffel, G.U. (1986). An estrogen-responsive element derived from the 5′ flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46, 1053-1061.
22. Klein-Hitpass, L., Ryffel, G.U., Heitlinger, E., and Cato, A.C. (1988). A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucleic Acids Res. 16, 647-663.
23. Kumar, V., and Chambon, P. (1988). The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55, 145-156.
24. Lammie, G.A., Fantl, V., Smith, R., Schuuring, E., Brookes, S., Michalides, R., Dickson, C., Arnold, A., and Peters, G. (1991). D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6, 439-444.
25. Lydon, J.P., DeMayo, F.J., Funk, C.R., Mani, S.K., Hughes, A.R., Montgomery, C.A., Jr., Shyamala, G., Conneely, O.M., and O'Malley, B.W. (1995). Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9, 2266-2278.
26. Matsushime, H., Roussel, M.F., Ashmun, R.A., and Sherr, C.J. (1991). Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65, 701-713.
27. Michalides, R., Hageman, Ph., van Tinteren, H., Houben, L., Wientjens, E., Klompmaker, R., and Peterse, H. (1996). A clinico-pathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br. J. Cancer 73, 728-734.
28. Migliaccio, A., Castoria, G., de Falco, A., Di Domenico, M., Galdiero, M., Nola, E., Chambon, P., and Auricchio, F. (1991). In vitro phosphorylation and hormone binding activation of the synthetic wild type human estradiol receptor. J. Steroid Biochem. Mol. Biol. 38, 407-413.
29. Motokura, T., Keyomarsi, K., Kronenberg, H.M., and Arnold, A. (1992). Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. J. Biol. Chem. 267, 20412-20415.
30. Musgrove, E.A., Lee, C.S., Buckley, M.F., and Sutherland, R.L. (1994). Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA 91, 8022-8026.
31. O'Malley, B.W., Schrader, W.T., Mani, S., Smith, C., Weigel, N.L., Conneely, O.M., and Clark, J.H. (1995). An alternative ligand-independent pathway for activation of steroid receptors. [review]. Recent Prog. Hormone Res. 50, 333-347.
32. Parry, D., Bates, S., Mann, D.J., and Peters, G. (1995). Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J. 14, 503-511.
33. Pratt, W.B. (1993). The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. [Review]. J. Biol. Chem. 268, 21455-21458.
34. Reeves, S.A., Rubio, M.P., and Louis, D.N. (1995). General method for PCR amplification and direct sequencing of mRNA differential display products. Biotechniques 18, 18-20.
35. Resnitzky, A., and Reed, S.I. (1995). Different roles for cyclin D1 and E in regulation of the G1-to-S transition. Mol. Cell. Biol. 15, 3463-3469.
36. Resnitzky, D., Gossen, M., Bujard, H., and Reed, S.I. (1994). Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14, 1669-1679.
37. Schuuring, E., Verhoeven, E., Mooi, W.J., and Michalides, R.J. (1992). Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7, 355-361.
38. Seed, B., and Sheen, J.Y. (1988). A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene 67, 271-277.
39. Sicinski, P., Donaher, J.L., Parker, S.B., Li, T., Fazeli, A., Gardner, H., Haslam, S.Z., Bronson, R.T., Elledge, S.J., and Weinberg, R.A. (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82, 621-630.
40. Tsai, S.Y., Carlstedt-Duke, J., Weigel, N.L., Dahlman, K., Gustafsson, J.A., Tsai, M.J., and O'Malley, B.W. (1988). Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell 55, 361-369.
41. Wang, Y., and Miksicek, R.J. (1991). Identification of a dominant negative form of the human estrogen receptor. Mol. Endocrinol. 5, 1707-1715.
42. Wang, T.C., Cardiff, R.D., Zukerberg, L., Lees, E., Arnold, A., and Schmidt, E.V. (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369, 669-671.
43. Webster, N.J., Green, S., Jin, J.R., and Chambon, P. (1988). The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 54, 199-207.
44. Weinberg, R.A. (1995). The retinoblastoma protein and cell cycle control. [review]. Cell 81, 323-330.
45. Weisz, A., and Bresciani, F. (1988). Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol. Endocrinol. 2, 816-824.
46. Wiltschke, C., and Fuqua, S.A. (1995). Clinical relevance of estrogen receptor variants in breast cancer. TEM 6, 77-82.
47. Xiong, Y., Menninger, J., Beach, D., and Ward, D.C. (1992). Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics 13, 575-584.
48. Zhang, Q.X., Borg, A., and Fuqua, S.A. (1993). An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer. Cancer Res. 53, 5882-5884.
49. Zhang, Y., Bai, W., Allgood, V.E., and Weigel, N.L. (1994). Multiple signaling pathways activate the chicken progesterone receptor. Mol. Endocrinol. 8, 577-584.
50. Zwijsen, R., Klompmaker, R., Wientjens, E., Kristel, P., Van der Burg, B., and Michalides, R.J. (1996). Cyclin D1 triggers autonomous growth of breast cancer cells by governing the cell cycle exit. Mol. Cell. Biol. 16, 2554-2560.